Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4abde64a2a4ff6ea75befbbecf72f6d5 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
filingDate |
2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d3c7d1d2583eab2605fc5c24cfddbce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5376788aa68081b84aee7d867449e571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed6d2b2ac5073087e5b54568c8a32622 |
publicationDate |
2018-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-108350463-A |
titleOfInvention |
Novel therapeutic tools and approaches to treat blindness by targeting photoreceptors |
abstract |
The present invention relates to an isolated nucleic acid molecule comprising a nucleotide sequence encoding a depolarized light-gated ion channel or a nucleotide sequence complementary to said nucleotide sequence, said coded depolarized light-gated ion channel The nucleotide sequence of the ion channel is functionally linked to a promoter leading to the specific expression of the depolarized light-gated ion channel in retinal photoreceptors, and the nucleic acid molecule is used for treating or improving blindness. The invention also relates to methods of using such nucleic acid molecules for the treatment of blindness. |
priorityDate |
2015-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |